Clinical Trial Participation AgreementClinical Trial Participation Agreement • June 7th, 2016 • District of Columbia
Contract Type FiledJune 7th, 2016 JurisdictionThis Clinical Trial Participation Agreement (the “Agreement”) is entered into by the National Cancer Institute, having its principal place of business at 9609 Medical Center Drive, Rockville, MD 20850 (“NCI”) and [Company Name], having its principal place of business at [Company Address] (“Pharmaceutical Collaborator”), on the other hand. NCI and Pharmaceutical Collaborator may be referred to herein individually as a “Party” and collectively as the “Parties.”